NASDAQ : BLTE
Belite Bio, Inc — Financial statements
Healthcare · Biotechnology · United States
Last price 154.74 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 6.23B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 59.88M | 38.83M | 10.06M | 6.82M | 3.95M | 2.38M |
| Research & Development | 58.81M | 45.38M | 29.94M | 24.84M | 8.87M | 7.42M |
| Operating Expenses | 118.69M | 84.21M | 40.00M | 31.67M | 12.82M | 9.80M |
| Operating Income | -118.69M | -84.21M | -40.00M | -31.67M | -12.82M | -9.80M |
| Interest Expense | -2.00K | -2.00K | -20.00K | -25.00K | -16.00K | |
| Interest & Investment Income | 6.64M | 6.64M | 3.74M | 74.00K | 23.00K | 5.00K |
| Currency Exchange Gain (Loss) | 166.00K | |||||
| Other Non Operating Income (Expenses) | 9.74M | -41.00K | 141.00K | -4.00K | 126.00K | |
| Pretax Income | -102.31M | -77.61M | -36.14M | -31.62M | -12.65M | -9.67M |
| Income Tax Expense | 55.00K | 6.00K | 9.00K | |||
| Net Income | -102.36M | -77.61M | -36.14M | -31.63M | -12.65M | -9.67M |
| Net Income to Common | -102.36M | -77.61M | -36.14M | -31.63M | -12.65M | -9.67M |
| Shares Outstanding (Basic) | 37.38M | 33.54M | 30.54M | 26.59M | 19.98M | 9.57M |
| Shares Outstanding (Diluted) | 37.38M | 33.54M | 30.54M | 26.59M | 19.98M | 9.57M |
| EPS (Basic) | -2.74 | -2.31 | -1.18 | -1.19 | -0.63 | -1.01 |
| EPS (Diluted) | -2.74 | -2.31 | -1.18 | -1.19 | -0.63 | -1.01 |
| Free Cash Flow | -37.17M | -29.35M | -29.90M | -11.85M | -7.55M | |
| Free Cash Flow Per Share | -1.11 | -0.96 | -1.12 | -0.59 | -0.79 | |
| EBITDA | -118.49M | -84.02M | -39.83M | -31.53M | -12.76M | -9.77M |
| D&A For EBITDA | 192.00K | 184.00K | 168.00K | 139.00K | 64.00K | 30.00K |
| EBIT | -118.69M | -84.21M | -40.00M | -31.67M | -12.82M | -9.80M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 352.93M | 31.68M | 88.16M | 42.09M | 17.34M | |
| Short-Term Investments | 139.49M | 113.47M | ||||
| Cash & Short-Term Investments | 492.42M | 145.15M | 88.16M | 42.09M | 17.34M | |
| Other Receivables | 700.00K | 575.00K | 836.00K | 2.00K | ||
| Receivables | 700.00K | 575.00K | 836.00K | 2.00K | ||
| Prepaid Expenses | 1.13M | 1.33M | 916.00K | 699.00K | 64.00K | |
| Other Current Assets | 501.60M | 23.00K | 19.00K | 31.00K | 17.00K | 23.00K |
| Total Current Assets | 501.60M | 494.27M | 147.07M | 89.94M | 42.81M | 17.43M |
| Property, Plant & Equipment | 777.00K | 965.00K | 1.30M | 1.35M | 94.00K | |
| Long-Term Investments | 280.17M | |||||
| Other Intangible Assets | 19.00K | 31.00K | ||||
| Long-Term Deferred Charges | 815.00K | |||||
| Other Long-Term Assets | 289.98M | 5.32M | 4.06M | 3.40M | 119.00K | 8.00K |
| Total Assets | 791.58M | 780.56M | 152.13M | 94.64M | 44.27M | 18.35M |
| Accrued Expenses | 7.31M | 4.86M | 3.18M | 1.83M | 1.54M | |
| Current Portion of Leases | 241.00K | 276.00K | 308.00K | 198.00K | ||
| Other Current Liabilities | 14.95M | 2.33M | 916.00K | 149.00K | 74.00K | 95.00K |
| Total Current Liabilities | 14.95M | 9.88M | 6.05M | 3.63M | 2.10M | 1.64M |
| Long-Term Leases | 188.00K | 261.00K | 578.00K | 668.00K | ||
| Total Liabilities | 14.95M | 10.07M | 6.31M | 4.21M | 2.77M | 1.64M |
| Common Stock | 776.64M | 4.00K | 3.00K | 3.00K | 3.00K | 1.00K |
| Additional Paid-In Capital | 956.28M | 254.12M | 162.31M | 81.76M | 12.32M | |
| Retained Earnings | -185.26M | -107.65M | -71.50M | -39.87M | -27.22M | |
| Comprehensive Income & Other | -536.00K | -660.00K | -374.00K | -392.00K | -196.00K | |
| Total Common Equity | 776.64M | 770.49M | 145.82M | 90.43M | 41.50M | -15.09M |
| Shareholders' Equity | 776.64M | 770.49M | 145.82M | 90.43M | 41.50M | 16.71M |
| Total Liabilities & Equity | 791.58M | 780.56M | 152.13M | 94.64M | 44.27M | 18.35M |
| Total Debt | 429.00K | 537.00K | 886.00K | 866.00K | ||
| Net Cash (Debt) | 491.99M | 144.61M | 87.27M | 41.22M | 17.34M | |
| Net Cash Per Share | 14.67 | 4.74 | 3.28 | 2.06 | 1.81 | |
| Filing Date Shares Outstanding | 40.27M | 39.34M | 31.83M | 29.15M | 24.90M | 10.27M |
| Total Common Shares Outstanding | 40.27M | 39.34M | 31.83M | 29.15M | 24.90M | 10.27M |
| Working Capital | 486.65M | 484.39M | 141.02M | 86.31M | 40.70M | 15.80M |
| Book Value Per Share | 19.28 | 19.59 | 4.58 | 3.10 | 1.67 | -1.47 |
| Tangible Book Value | 776.64M | 770.47M | 145.79M | 90.43M | 41.50M | -15.09M |
| Tangible Book Value Per Share | 19.28 | 19.58 | 4.58 | 3.10 | 1.67 | -1.47 |
| Machinery | 664.00K | 598.00K | 486.00K | 445.00K | 141.00K | |
| Leasehold Improvements | 187.00K | 187.00K | 187.00K | 187.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -77.61M | -36.14M | -31.63M | -12.65M | -9.67M | |
| Depreciation & Amortization | 184.00K | 168.00K | 139.00K | 198.00K | 30.00K | |
| Loss (Gain) From Sale of Assets | -8.00K | |||||
| Loss (Gain) From Sale of Investments | -49.00K | |||||
| Stock-Based Compensation | 38.92M | 8.99M | 3.82M | 1.48M | 1.53M | |
| Other Operating Activities | -1.03M | -3.33M | 260.00K | |||
| Change in Accounts Receivable | 18.00K | -16.00K | -32.00K | |||
| Change in Accounts Payable | -8.00K | 13.00K | -41.00K | 45.00K | ||
| Change in Other Net Operating Assets | 2.56M | 1.10M | -2.41M | -418.00K | 595.00K | |
| Operating Cash Flow | -36.99M | -29.23M | -29.84M | -11.46M | -7.47M | |
| Capital Expenditures | -178.00K | -116.00K | -63.00K | -394.00K | -74.00K | |
| Sale of Property, Plant & Equipment | 18.00K | |||||
| Sale (Purchase) of Intangibles | -35.00K | |||||
| Investment in Securities | -304.93M | -110.42M | ||||
| Investing Cash Flow | -305.11M | -110.57M | -63.00K | -394.00K | -56.00K | |
| Issuance of Common Stock | 139.81M | 58.20M | 77.19M | 37.99M | 232.00K | |
| Other Financing Activities | 523.42M | 25.39M | -1.23M | -1.03M | -815.00K | |
| Financing Cash Flow | 663.23M | 83.59M | 75.96M | 36.96M | -583.00K | |
| Foreign Exchange Rate Adjustments | 117.00K | -269.00K | 9.00K | -366.00K | -161.00K | |
| Net Cash Flow | 321.25M | -56.48M | 46.07M | 24.75M | -8.27M | |
| Free Cash Flow | -37.17M | -29.35M | -29.90M | -11.85M | -7.55M | |
| Free Cash Flow Per Share | -1.11 | -0.96 | -1.12 | -0.59 | -0.79 | |
| Levered Free Cash Flow | -9.77M | -13.70M | -15.56M | -7.10M | -4.01M | |
| Unlevered Free Cash Flow | -9.76M | -13.69M | -15.54M | -7.09M | -4.01M | |
| Cash Interest Paid | 1.00K | 16.00K | ||||
| Cash Income Tax Paid | 6.00K | 9.00K | ||||
| Change in Working Capital | 2.55M | 1.13M | -2.43M | -491.00K | 640.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 6.22B | 6.00B | 1.95B | 1.26B | 749.63M | |
| Enterprise Value | 5.73B | 5.73B | 1.86B | 1.22B | 700.93M | |
| Last Close Price | 154.74 | 159.96 | 63.10 | 45.75 | 30.14 | |
| PB Ratio | 8.02 | 7.79 | 13.36 | 13.96 | 18.06 | |
| P/TBV Ratio | 7.99 | 7.79 | 13.37 | 13.96 | 18.06 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | ||
| Net Debt / Equity Ratio | -0.64 | -0.99 | -0.96 | -0.99 | -1.04 | |
| Net Debt / EBITDA Ratio | 5.86 | 3.63 | 2.77 | 3.23 | 1.78 | |
| Net Debt / FCF Ratio | 13.24 | 4.93 | 2.92 | 3.48 | 2.30 | |
| Quick Ratio | 49.90 | 24.09 | 24.50 | 20.00 | 10.61 | |
| Current Ratio | 33.56 | 50.02 | 24.31 | 24.76 | 20.35 | 10.66 |
| Return on Equity (ROE) | -22.10% | -16.94% | -30.60% | -47.95% | -43.45% | -46.60% |
| Return on Assets (ROA) | -15.65% | -11.29% | -20.26% | -28.50% | -25.59% | -27.78% |
| Return on Capital Employed (ROCE) | -15.30% | -10.90% | -27.40% | -34.80% | -30.40% | -58.60% |
| Earnings Yield | -1.77% | -1.29% | -1.85% | -2.50% | -1.69% | |
| FCF Yield | -0.60% | -0.62% | -1.51% | -2.37% | -1.58% | |
| Buyback Yield / Dilution | -17.91% | -9.82% | -14.83% | -33.12% | -108.74% | -8.87% |